{
  "Q0": "BRCA1/2 and multigene panel testing for breast cancer susceptibility",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4-Does the patient's clinical presentation match the criteria in those guidelines?": "Yes",
  "Q4-Which guideline(s) apply?": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9-Does this patient have a relevant family history or consanguinity that aligns with the policy?": "Yes",
  "Q10": "No",
  "Q10-If 'No'": "Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14-Please specify the CPT code": "81432",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "According to the policy, an 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form' must be completed by the provider and submitted along with the Laboratory's Test Requisition Form to Aetna for precertification. Documentation of the specific cancer diagnosis and pertinent medical records may be required. A summary indicating how this testing will change the immediate medical care of the member must also be included with the Prior Authorization request. The blood specimen should not be tested until confirmation of coverage is received and the test is precertified.",
  "match": true
}